Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management

Published:2017-05 Issue:5 Volume:29 Page:307-309
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Newbold K.L.,Flux G.^ORCID,Wadsley J.

Funder

NHS Executive

National Institute for Health Research Royal Marsden

Institute of Cancer Research Biomedical Research Centre

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference18 articles.

1. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer;Mallick;N Eng J Med,2012

2. Strategies of radioiodine ablation in patients with low-risk thyroid cancer;Schlumberger;N Engl J Med,2012

3. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer;Haugen;Thyroid,2016

4. Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients;Verburg;Eur J Endocrinol,2005

5. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer;Ho;New Engl J Med,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer;Frontiers in Oncology;2021-07-08

2. Cancer of the Thyroid;Practical Medical Oncology Textbook;2021

3. Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation;Health Technology Assessment;2020-01

4. A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine;BMC Cancer;2019-12

5. Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approach;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2019-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3